SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-17-164346
Filing Date
2017-05-09
Accepted
2017-05-09 17:01:59
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d391312ds3.htm S-3 214812
2 EX-5.1 d391312dex51.htm EX-5.1 20535
3 EX-23.1 d391312dex231.htm EX-23.1 1790
4 GRAPHIC g391312g0509043016845.jpg GRAPHIC 4297
  Complete submission text file 0001193125-17-164346.txt   244498
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: S-3 | Act: 33 | File No.: 333-217808 | Film No.: 17827354
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10